Kristin has 30 years of experience in strategy consulting and research in the healthcare and life sciences industries.
Her areas of focus are commercial strategy, growth strategy, and M&A for pharmaceutical, diagnostics, device, and consumer health companies, investors, and medical institutions worldwide.
At KPMG, she leads Life Sciences across both the US and the Americas region and is the Global Healthcare and Life Sciences Deal Advisory and Strategy leader. She is responsible for developing and operationalizing business strategies, building cross-region capabilities and representing KPMG as a keynote speaker and facilitator at industry events.
She is also a leader in precision medicine and in clinical laboratory innovation, developing product and service strategies and operations with on-the-ground experience in North America, Latin America, Europe, Asia, India, the Middle East, and the Caribbean. Her book, Personalizing Precision Medicine, has garnered attention worldwide for its all-inclusive and comprehensive look at global precision medicine. A sequel to this book is planned for 2026.
In 2019, Kristin joined KPMG from another Big Four firm where she was the Global Head of Life Sciences Strategy, responsible for growing the business from a single deals-focused office to a full-service global strategy practice. Earlier in her career, she helped build Health Advances, a healthcare strategy firm (now part of Parexel), and was a scientist and clinical diagnostics developer at Genome Therapeutics and Genzyme/Sanofi.